The purpose of this study is to study the impact of stem cell dose on outcome after autologous transplant.
SparkCures ID | 1271 |
---|---|
Trial Phase | Phase 2 |
Enrollment | 59 Patients |
Treatments | |
Tags |
|
Trial Sponsors |
|
Trial Collaborators |
|
NCT Identifier |
|
The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.
The following criteria is provided for health care professionals.
Inclusion Criteria:
Exclusion Criteria:
Please visit the ClinicalTrials.gov page for historical site information.
View CentersLearn more about how we work with trial sponsors